$CATX
Perspective Therapeutics, Inc. Stock $catx

$catx Overview Financials Valuation SEC Filings Company Website

2021 Q2 Form 10-Q Financial Statement

#000143774921012141 Filed on May 14, 2021

Income Statement

Concept	2021 Q2	2021 Q1	2020 Q1
Revenue	$2.710M	$2.600M	$2.880M
YoY Change	18.91%	-9.72%	49.69%
Cost Of Revenue	$1.364M	$1.238M	$1.174M
YoY Change	12.91%	5.45%	12.34%
Gross Profit	$1.346M	$1.362M	$1.706M
YoY Change	25.68%	-20.16%	94.08%
Gross Profit Margin	49.67%	52.38%	59.24%
Selling, General & Admin	$1.971M	$1.764M	$1.960M
YoY Change	1.7%	-10.0%	12.39%
% of Gross Profit	146.43%	129.52%	114.89%
Research & Development	$468.0K	$362.0K	$294.0K
YoY Change	45.34%	23.13%	-1.67%
% of Gross Profit	34.77%	26.58%	17.23%
Depreciation & Amortization	$51.00K	$45.00K	$45.00K
YoY Change	18.6%	0.0%	-4.26%
% of Gross Profit	3.79%	3.3%	2.64%
Operating Expenses	$2.439M	$2.128M	$2.254M
YoY Change	7.92%	-5.59%	10.38%
Operating Profit	-$1.093M	-$766.0K	-$548.0K
YoY Change	-8.07%	39.78%	-52.88%
Interest Expense	$32.00K	$21.00K	$3.000K
YoY Change	3100.0%	600.0%	-91.18%
% of Operating Profit
Other Income/Expense, Net		$21.00K	$3.000K
YoY Change		600.0%	-91.67%
Pretax Income	-$1.061M	-$745.0K	-$545.0K
YoY Change	-10.69%	36.7%	-51.64%
Income Tax
% Of Pretax Income
Net Earnings	-$1.061M	-$745.0K	-$545.0K
YoY Change	-10.69%	36.7%	-51.64%
Net Earnings / Revenue	-39.15%	-28.65%	-18.92%
Basic Earnings Per Share	-$0.01	-$0.01
Diluted Earnings Per Share	-$7.496K	-$6.078K	-$8.067K
COMMON SHARES
Basic Shares Outstanding	141.5M	122.6M
Diluted Shares Outstanding

Balance Sheet

Concept	2021 Q2	2021 Q1	2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$63.83M	$64.84M	$2.405M
YoY Change	2568.39%	2596.09%	-62.37%
Cash & Equivalents	$63.83M	$64.84M	$2.405M
Short-Term Investments
Other Short-Term Assets	$27.00K	$483.0K	$587.0K
YoY Change	0.0%	-17.72%	50.51%
Inventory	$980.0K	$731.0K	$580.0K
Prepaid Expenses
Receivables	$2.013M	$2.019M	$2.147M
Other Receivables	$32.00K	$0.00	$0.00
Total Short-Term Assets	$67.30M	$68.07M	$5.719M
YoY Change	1122.12%	1090.31%	-32.17%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.958M	$1.885M	$1.744M
YoY Change	12.85%	8.08%	11.51%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$130.0K	$117.0K	$133.0K
YoY Change	-5.8%	-12.03%	-16.88%
Total Long-Term Assets	$3.114M	$3.206M	$3.243M
YoY Change	-2.44%	-1.14%	50.98%
TOTAL ASSETS
Total Short-Term Assets	$67.30M	$68.07M	$5.719M
Total Long-Term Assets	$3.114M	$3.206M	$3.243M
Total Assets	$70.42M	$71.28M	$8.962M
YoY Change	709.47%	695.36%	-15.28%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$730.0K	$992.0K	$937.0K
YoY Change	11.62%	5.87%	-6.39%
Accrued Expenses	$1.071M	$924.0K	$807.0K
YoY Change	16.29%	14.5%	127.97%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.801M	$1.916M	$1.744M
YoY Change	14.35%	9.86%	28.71%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$1.209M	$1.266M	$1.400M
YoY Change	-13.7%	-9.57%	128.38%
Total Long-Term Liabilities	$1.209M	$1.266M	$1.400M
YoY Change	-13.7%	-9.57%	128.38%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.801M	$1.916M	$1.744M
Total Long-Term Liabilities	$1.209M	$1.266M	$1.400M
Total Liabilities	$3.010M	$3.182M	$3.144M
YoY Change	1.14%	1.21%	59.76%
SHAREHOLDERS EQUITY
Retained Earnings	-$91.33M	-$90.26M	-$86.75M
YoY Change	3.85%	4.05%	4.02%
Common Stock	$158.7M	$158.4M	$92.57M
YoY Change	69.47%	71.08%	0.61%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$67.41M	$68.10M	$5.818M
YoY Change
Total Liabilities & Shareholders Equity	$70.42M	$71.28M	$8.962M
YoY Change	709.47%	695.36%	-15.28%

Cashflow Statement

Concept	2021 Q2	2021 Q1	2020 Q1
OPERATING ACTIVITIES
Net Income	-$1.061M	-$745.0K	-$545.0K
YoY Change	-10.69%	36.7%	-51.64%
Depreciation, Depletion And Amortization	$51.00K	$45.00K	$45.00K
YoY Change	18.6%	0.0%	-4.26%
Cash From Operating Activities	-$1.118M	-$621.0K	-$862.0K
YoY Change	31.84%	-27.96%	-35.58%
INVESTING ACTIVITIES
Capital Expenditures	-$138.0K	-$100.0K	-$44.00K
YoY Change	253.85%	127.27%	-65.62%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$1.000K	$0.00
YoY Change			-100.0%
Cash From Investing Activities	-$138.0K	-$99.00K	-$44.00K
YoY Change	253.85%	125.0%	-102.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$51.75M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	243.0K	55.98M	131.0K
YoY Change	-72.2%	42629.77%	-1555.56%
NET CHANGE
Cash From Operating Activities	-1.118M	-621.0K	-862.0K
Cash From Investing Activities	-138.0K	-99.00K	-44.00K
Cash From Financing Activities	243.0K	55.98M	131.0K
Net Change In Cash	-1.013M	55.26M	-775.0K
YoY Change	7692.31%	-7229.81%	-190.33%
FREE CASH FLOW
Cash From Operating Activities	-$1.118M	-$621.0K	-$862.0K
Capital Expenditures	-$138.0K	-$100.0K	-$44.00K
Free Cash Flow	-$980.0K	-$521.0K	-$818.0K
YoY Change	21.14%	-36.31%	-32.4%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
	dei	Document Period End Date DocumentPeriodEndDate	2021-03-31
	dei	Document Type DocumentType	10-Q
CY2021Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	141465266
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Shell Company EntityShellCompany	false
	dei	Security12b Title Security12bTitle	Common Stock, $0.001 par value
CY2021Q1	isr	Accrued Payroll And Related Taxes Current AccruedPayrollAndRelatedTaxesCurrent	221000
CY2020Q2	isr	Accrued Payroll And Related Taxes Current AccruedPayrollAndRelatedTaxesCurrent	352000
CY2021Q1	isr	Accrued Payroll And Related Taxes Noncurrent AccruedPayrollAndRelatedTaxesNoncurrent	77000
CY2020Q2	isr	Accrued Payroll And Related Taxes Noncurrent AccruedPayrollAndRelatedTaxesNoncurrent	55000
CY2019Q3	isr	Aro Discount Amount Interest Rate AroDiscountAmountInterestRate	0.051
CY2019Q3	isr	Aro Original Obligation Amount AroOriginalObligationAmount	704000
CY2019Q3	isr	Asset Retirement Obligation After Adjustment AssetRetirementObligationAfterAdjustment	555000
	isr	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Exercised ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsExercised
	isr	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Exercised ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsExercised	0.63
	isr	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Expired ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsExpired
	isr	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Expired ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsExpired	0.54
	isr	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Issued ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsIssued
	isr	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Issued ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsIssued	0.57
CY2021Q1	isr	Class Of Warrant Or Right Exercised During Period ClassOfWarrantOrRightExercisedDuringPeriod	12318877
	isr	Class Of Warrant Or Right Exercised During Period ClassOfWarrantOrRightExercisedDuringPeriod
	isr	Class Of Warrant Or Right Exercised During Period ClassOfWarrantOrRightExercisedDuringPeriod	12318877
	isr	Class Of Warrant Or Right Expired ClassOfWarrantOrRightExpired
	isr	Class Of Warrant Or Right Expired ClassOfWarrantOrRightExpired	250000
	isr	Class Of Warrant Or Right Issued For Services ClassOfWarrantOrRightIssuedForServices
	isr	Class Of Warrant Or Right Issued For Services ClassOfWarrantOrRightIssuedForServices	9134615
CY2019Q3	isr	Gain Loss On Change In Aro Estimate GainLossOnChangeInAROEstimate	73000
	isr	Gain Loss On Change In Aro Estimate GainLossOnChangeInAROEstimate
	isr	Gain Loss On Change In Aro Estimate GainLossOnChangeInAROEstimate	73000
CY2021Q1	isr	Gain Loss On Change In Aro Estimate GainLossOnChangeInAROEstimate
CY2020Q1	isr	Gain Loss On Change In Aro Estimate GainLossOnChangeInAROEstimate
	isr	Increase Decrease In Accrued Payroll And Related Taxes IncreaseDecreaseInAccruedPayrollAndRelatedTaxes	-109000
	isr	Increase Decrease In Accrued Payroll And Related Taxes IncreaseDecreaseInAccruedPayrollAndRelatedTaxes	171000
	isr	Increase Decrease In Accrued Protocol Expense IncreaseDecreaseInAccruedProtocolExpense	80000
	isr	Increase Decrease In Accrued Protocol Expense IncreaseDecreaseInAccruedProtocolExpense	-88000
	isr	Increase Decrease In Accrued Vacation IncreaseDecreaseInAccruedVacation	36000
	isr	Increase Decrease In Accrued Vacation IncreaseDecreaseInAccruedVacation	41000
	isr	Increase Decrease In Operating Lease Right Of Use Asset IncreaseDecreaseInOperatingLeaseRightOfUseAsset	8000
CY2020Q1	isr	Maximum Amount Of Equity Securities That Could Be Registered MaximumAmountOfEquitySecuritiesThatCouldBeRegistered	80000000
CY2020Q4	isr	Proceeds From Issuance Of Common Stock Net Of Issuance Costs ProceedsFromIssuanceOfCommonStockNetOfIssuanceCosts	8595000
CY2021Q1	isr	Restocking Fee Percentage RestockingFeePercentage	0.5
CY2021Q1	isr	Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodFairValue	152000
CY2020Q1	isr	Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodFairValue	0
	isr	Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodFairValue	170000
	isr	Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodFairValue	14000
CY2021Q1	isr	Stock Issued During Period Value Exercise Of Warrants StockIssuedDuringPeriodValueExerciseOfWarrants	7784000
CY2021Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	992000
CY2020Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	654000
CY2021Q1	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	115000
CY2020Q2	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	35000
CY2021Q1	us-gaap	Accrued Vacation Current AccruedVacationCurrent	240000
CY2020Q2	us-gaap	Accrued Vacation Current AccruedVacationCurrent	204000
CY2021Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	7301000
CY2020Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	7517000
CY2021Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	158221000
CY2020Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	93592000
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	28000
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	29000
CY2019Q4	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings	11000
CY2020Q4	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings	9000
CY2019Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	91000
CY2019Q4	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	94000
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	91000
CY2020Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	85000
CY2020Q4	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	81000
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	94000
CY2021Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	94000
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2573000
CY2019Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5507000
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	65023000
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2586000
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	62450000
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2921000
CY2021Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1238000
CY2020Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1174000
CY2020Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	91000
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	260000
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	276000
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7553000
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	10506000
CY2020Q2	us-gaap	Asset Retirement Obligation AssetRetirementObligation	577000
CY2019Q2	us-gaap	Asset Retirement Obligation AssetRetirementObligation	621000
CY2021Q1	us-gaap	Asset Retirement Obligation AssetRetirementObligation	600000
CY2020Q1	us-gaap	Asset Retirement Obligation AssetRetirementObligation	570000
	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	23000
	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	22000
CY2021Q1	us-gaap	Asset Retirement Obligations Noncurrent AssetRetirementObligationsNoncurrent	600000
CY2020Q2	us-gaap	Asset Retirement Obligations Noncurrent AssetRetirementObligationsNoncurrent	577000
CY2021Q1	us-gaap	Assets Assets	71280000
CY2020Q2	us-gaap	Assets Assets	8699000
CY2021Q1	us-gaap	Assets Current AssetsCurrent	68074000
CY2020Q2	us-gaap	Assets Current AssetsCurrent	5507000
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	64841000
CY2020Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2392000
CY2020Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2405000
CY2019Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.75
CY2020Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.75
CY2020Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.75
CY2021Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.70
CY2019Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	6080000
CY2020Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	6080000
CY2020Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	6080000
CY2021Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	2645738
CY2021Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2020Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2021Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2020Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000
CY2020Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000
CY2021Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	141465266
CY2020Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	68897779
CY2021Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	141465266
CY2020Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	68897779
CY2021Q1	us-gaap	Common Stock Value CommonStockValue	141000
CY2020Q2	us-gaap	Common Stock Value CommonStockValue	69000
CY2021Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	201000
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	3568000
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	3348000
	us-gaap	Depreciation Depreciation	107000
	us-gaap	Depreciation Depreciation	113000
CY2021Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.01
CY2020Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.01
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.03
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.03
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2021Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	480000
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y36D
CY2021Q1	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-2000
CY2020Q1	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-9000
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-10000
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment
CY2021Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1183000
CY2020Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1155000
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3379000
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3323000
CY2021Q1	us-gaap	Gross Profit GrossProfit	1362000
CY2020Q1	us-gaap	Gross Profit GrossProfit	1706000
	us-gaap	Gross Profit GrossProfit	3775000
	us-gaap	Gross Profit GrossProfit	4053000
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	340000
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	258000
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-25000
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	993000
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	141000
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	21000
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	5000
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	13000
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	57000
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	283000
CY2021Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	22000
CY2020Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	23000
CY2021Q1	us-gaap	Inventory Net InventoryNet	731000
CY2020Q2	us-gaap	Inventory Net InventoryNet	645000
CY2021Q1	us-gaap	Inventory Noncurrent InventoryNoncurrent	192000
CY2020Q2	us-gaap	Inventory Noncurrent InventoryNoncurrent	137000
CY2021Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	508000
CY2020Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	401000
CY2020Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	221000
CY2021Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	21000
CY2020Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	3000
	us-gaap	Investment Income Interest InvestmentIncomeInterest	27000
	us-gaap	Investment Income Interest InvestmentIncomeInterest	29000
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	921000
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	292000
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	264000
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	292000
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	73000
	us-gaap	Net Income Loss NetIncomeLoss	-2258000
CY2021Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	83000
CY2019Q3	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P5Y
CY2021Q1	us-gaap	Liabilities Liabilities	3182000
CY2020Q2	us-gaap	Liabilities Liabilities	2976000
CY2021Q1	us-gaap	Liabilities Current LiabilitiesCurrent	1916000
CY2020Q2	us-gaap	Liabilities Current LiabilitiesCurrent	1575000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	64441000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	120000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-272000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-248000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1719000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2793000
	us-gaap	Net Income Loss NetIncomeLoss	-2326000
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	-816000
CY2019Q4	us-gaap	Net Income Loss NetIncomeLoss	-897000
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-545000
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-713000
CY2020Q4	us-gaap	Net Income Loss NetIncomeLoss	-868000
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-745000
CY2021Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-745000
CY2020Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-548000
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2329000
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2266000
CY2021Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	21000
CY2020Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	3000
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	27000
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	29000
CY2021Q1	us-gaap	Operating Expenses OperatingExpenses	2128000
CY2020Q1	us-gaap	Operating Expenses OperatingExpenses	2254000
	us-gaap	Operating Expenses OperatingExpenses	6128000
	us-gaap	Operating Expenses OperatingExpenses	6340000
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-766000
CY2020Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-548000
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2353000
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2287000
CY2021Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	75000
CY2020Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	73000
	us-gaap	Operating Lease Expense OperatingLeaseExpense	227000
	us-gaap	Operating Lease Expense OperatingLeaseExpense	220000
CY2021Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	838000
CY2021Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	249000
CY2020Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	236000
CY2021Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	589000
CY2020Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	769000
CY2021Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	830000
CY2020Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1001000
CY2021Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.06
CY2021Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y36D
CY2021Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	117000
CY2020Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	138000
CY2021Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	99000
CY2020Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	94000
	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	9000
	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	11000
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	7000
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	266000
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	248000
CY2021Q1	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact
CY2020Q1	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	3000
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	3000
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	8000
CY2021Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2020Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	7000000
CY2020Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	7000000
CY2021Q1	us-gaap	Preferred Stock Value PreferredStockValue
CY2020Q2	us-gaap	Preferred Stock Value PreferredStockValue
CY2021Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	483000
CY2020Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	426000
CY2020Q4	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	9500000
CY2021Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	45000000
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	56375000
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	1000
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	7784000
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises
CY2021Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	9186000
CY2020Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	9252000
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment
CY2021Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	300000
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	291000
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	131000
CY2021Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	7800000
CY2021Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1885000
CY2020Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1735000
CY2021Q1	us-gaap	Receivables Net Current ReceivablesNetCurrent	2019000
CY2020Q2	us-gaap	Receivables Net Current ReceivablesNetCurrent	2044000
CY2021Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	362000
CY2020Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	294000
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	959000
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	804000
CY2021Q1	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	182000
CY2020Q2	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	181000
CY2020Q1	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	181000
CY2021Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-90264000
CY2020Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-87938000
CY2021Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	2600000
CY2020Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	2880000
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	7343000
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	7401000
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	8000
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1228000
CY2021Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	581000
CY2020Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	805000
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1781000
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2286000
	us-gaap	Share Based Compensation ShareBasedCompensation	260000
	us-gaap	Share Based Compensation ShareBasedCompensation	276000
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	3393000
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.67
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	652000
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	83000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	653000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	83000
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	2000
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	21250
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	4000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	29500
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	234375
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	237500
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	26250
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	125000
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	165000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	40000
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	2385000
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4907000
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.65
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	1608000
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	2385000
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	4907000
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	0.65
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y43D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P6Y146D
CY2020Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	131000
CY2020Q4	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	3000
CY2021Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	288000
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P7Y43D
CY2020Q4	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.52
CY2021Q1	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	1.25
CY2020Q4	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	18269230
CY2021Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	514065
CY2020Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	262500
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	520315
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	262500
CY2020Q4	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	8471000
CY2021Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	47904000
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	68098000
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	5723000
CY2019Q2	us-gaap	Stockholders Equity StockholdersEquity	7680000
CY2019Q3	us-gaap	Stockholders Equity StockholdersEquity	6955000
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	6141000
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	5818000
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	5095000
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	12773000
CY2021Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	122566000
CY2020Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	67558000
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	91277000
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	67444000

Files In Submission

Name	View Source	Status
0001437749-21-012141-index-headers.html	Edgar Link	pending
0001437749-21-012141-index.html	Edgar Link	pending
0001437749-21-012141.txt	Edgar Link	pending
0001437749-21-012141-xbrl.zip	Edgar Link	pending
ex_242816.htm	Edgar Link	pending
ex_242817.htm	Edgar Link	pending
ex_242818.htm	Edgar Link	pending
ex_242819.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
isr-20210331.xml	Edgar Link	completed
isr-20210331.xsd	Edgar Link	pending
isr-20210331_cal.xml	Edgar Link	unprocessable
isr-20210331_def.xml	Edgar Link	unprocessable
isr-20210331_lab.xml	Edgar Link	unprocessable
isr-20210331_pre.xml	Edgar Link	unprocessable
isr20210331_10q.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CATX
Perspective Therapeutics, Inc. Stock $catx

2021 Q2 Form 10-Q Financial Statement

#000143774921012141 Filed on May 14, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CATX Perspective Therapeutics, Inc. Stock $catx

2021 Q2 Form 10-Q Financial Statement

#000143774921012141 Filed on May 14, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CATX
Perspective Therapeutics, Inc. Stock $catx